Background: Management of cancer treatment-related skin toxicities can minimize treatment disruptions and improve patient well-being.
Objectives: This guideline aims to support patients and clinicians in decisions regarding management of cancer treatment-related skin toxicities.
Methods: A panel developed a guideline for management of cancer treatment-related skin toxicities using GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) for certainty of evidence and the National Academies of Sciences, Engineering, and Medicine criteria for trustworthy guidelines.